Tapewire

Nasdaq · USD

WTW

WILLIS TOWERS WATSON PLC

Export transactions ↓
Tapewire entity
3139
SEC CIK
0001140536
Parsed reports
1,677

Last 12 months

Inside the activity.

4 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202620
Mar 202601
Apr 202600
May 202620
Jun 202600
Jul 202600
Aug 202601
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 07, 2022 Filed Oct 11, 2022 20:10 UTC
Faber AlexisChief Operating Officer
GrantRestricted Share Unit · Derivative 14.088 $204.93 $2,887.05
Disclosure

SEC source: 0001127602-22-023853 · form4.xml · derivative · entry 3

Faber Alexis · CIK 0001882149 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 713.946

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 14.088 shares

Expires not disclosed

F4 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F5 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees.

F4 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F4 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:10 UTC
Faber AlexisChief Operating Officer
GrantRestricted Share Unit · Derivative 24.6537 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-023853 · form4.xml · derivative · entry 2

Faber Alexis · CIK 0001882149 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,467.9527

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 24.6537 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan.

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:10 UTC
Faber AlexisChief Operating Officer
GrantRestricted Share Unit · Derivative 42.2637 $204.93 $8,661.10
Disclosure

SEC source: 0001127602-22-023853 · form4.xml · derivative · entry 1

Faber Alexis · CIK 0001882149 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,443.299

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 42.2637 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for US Employees (the "Plan").

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:08 UTC
WICKES GENE HHead of Benefits Deliv & Admin
GrantRestricted Share Unit · Derivative 27.8697 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-023852 · form4.xml · derivative · entry 2

WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,038.7991

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 27.8697 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan.

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:08 UTC
WICKES GENE HHead of Benefits Deliv & Admin
GrantRestricted Share Unit · Derivative 47.7764 $204.93 $9,790.82
Disclosure

SEC source: 0001127602-22-023852 · form4.xml · derivative · entry 1

WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,010.9294

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 47.7764 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan").

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:07 UTC
Qureshi Imran AhmedHead of North America
GrantRestricted Share Unit · Derivative 23.5818 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-023851 · form4.xml · derivative · entry 2

Qureshi Imran Ahmed · CIK 0001881795 · Head of North America

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,989.7319

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 23.5818 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan.

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:07 UTC
Qureshi Imran AhmedHead of North America
GrantRestricted Share Unit · Derivative 40.4261 $204.93 $8,284.52
Disclosure

SEC source: 0001127602-22-023851 · form4.xml · derivative · entry 1

Qureshi Imran Ahmed · CIK 0001881795 · Head of North America

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,966.1501

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 40.4261 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan").

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:06 UTC
Pullum AnneHead of Europe
GrantRestricted Share Unit · Derivative 15.3129 $204.93 $3,138.07
Disclosure

SEC source: 0001127602-22-023850 · form4.xml · derivative · entry 3

Pullum Anne · CIK 0001688834 · Head of Europe

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 634.1546

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 15.3129 shares

Expires not disclosed

F4 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F5 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees.

F4 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F4 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:06 UTC
Pullum AnneHead of Europe
GrantRestricted Share Unit · Derivative 32.3947 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-023850 · form4.xml · derivative · entry 2

Pullum Anne · CIK 0001688834 · Head of Europe

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,382.3421

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 32.3947 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan.

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:06 UTC
Pullum AnneHead of Europe
GrantRestricted Share Unit · Derivative 55.5337 $204.93 $11,380.52
Disclosure

SEC source: 0001127602-22-023850 · form4.xml · derivative · entry 1

Pullum Anne · CIK 0001688834 · Head of Europe

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,349.9474

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 55.5337 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for US Employees (the "Plan").

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:05 UTC
Kurpis Joseph StephenPAO and Controller
GrantRestricted Share Unit · Derivative 13.8658 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-023849 · form4.xml · derivative · entry 2

Kurpis Joseph Stephen · CIK 0001497048 · PAO and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164.5404

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 13.8658 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan.

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:05 UTC
Kurpis Joseph StephenPAO and Controller
GrantRestricted Share Unit · Derivative 23.7698 $204.93 $4,871.15
Disclosure

SEC source: 0001127602-22-023849 · form4.xml · derivative · entry 1

Kurpis Joseph Stephen · CIK 0001497048 · PAO and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150.6746

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 23.7698 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan").

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:04 UTC
Krasner Andrew JayChief Financial Officer
GrantRestricted Share Unit · Derivative 19.6006 $204.93 $4,016.75
Disclosure

SEC source: 0001127602-22-023848 · form4.xml · derivative · entry 3

Krasner Andrew Jay · CIK 0001881781 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90.8711

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 19.6006 shares

Expires not disclosed

F4 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F5 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees.

F4 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F4 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:04 UTC
Krasner Andrew JayChief Financial Officer
GrantRestricted Share Unit · Derivative 34.3009 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-023848 · form4.xml · derivative · entry 2

Krasner Andrew Jay · CIK 0001881781 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 212.4471

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 34.3009 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan.

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:04 UTC
Krasner Andrew JayChief Financial Officer
GrantRestricted Share Unit · Derivative 58.8014 $204.93 $12,050.17
Disclosure

SEC source: 0001127602-22-023848 · form4.xml · derivative · entry 1

Krasner Andrew Jay · CIK 0001881781 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 178.1462

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 58.8014 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan").

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:03 UTC
Hess Carl AaronDirector · Chief Executive Officer
GrantRestricted Share Unit · Derivative 42.8767 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-023846 · form4.xml · derivative · entry 2

Hess Carl Aaron · CIK 0001435988 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,138.8021

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 42.8767 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan.

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:03 UTC
Hess Carl AaronDirector · Chief Executive Officer
GrantRestricted Share Unit · Derivative 73.5031 $204.93 $15,062.99
Disclosure

SEC source: 0001127602-22-023846 · form4.xml · derivative · entry 1

Hess Carl Aaron · CIK 0001435988 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,095.9254

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 73.5031 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan").

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:02 UTC
Gebauer Julie JareckeHead of Health, Wealth &Career
GrantRestricted Share Unit · Derivative 27.8697 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-023845 · form4.xml · derivative · entry 2

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,590.18

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 27.8697 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan.

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:02 UTC
Gebauer Julie JareckeHead of Health, Wealth &Career
GrantRestricted Share Unit · Derivative 47.7765 $204.93 $9,790.84
Disclosure

SEC source: 0001127602-22-023845 · form4.xml · derivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,562.3103

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 47.7765 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan").

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:02 UTC
Furman MatthewGeneral Counsel
GrantRestricted Share Unit · Derivative 14.4556 $204.93 $2,962.39
Disclosure

SEC source: 0001127602-22-023844 · form4.xml · derivative · entry 3

Furman Matthew · CIK 0001637389 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,910.8358

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 14.4556 shares

Expires not disclosed

F4 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F5 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees.

F4 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F4 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:02 UTC
Furman MatthewGeneral Counsel
GrantRestricted Share Unit · Derivative 25.2972 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-023844 · form4.xml · derivative · entry 2

Furman Matthew · CIK 0001637389 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,008.0403

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 25.2972 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan.

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:02 UTC
Furman MatthewGeneral Counsel
GrantRestricted Share Unit · Derivative 43.3665 $204.93 $8,887.10
Disclosure

SEC source: 0001127602-22-023844 · form4.xml · derivative · entry 1

Furman Matthew · CIK 0001637389 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,982.7431

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 43.3665 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan").

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:01 UTC
Bodnar Anne DonovanChief Administrative Officer
GrantRestricted Share Unit · Derivative 23.5819 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-023843 · form4.xml · derivative · entry 2

Bodnar Anne Donovan · CIK 0001629374 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,897.2371

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 23.5819 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan.

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:01 UTC
Bodnar Anne DonovanChief Administrative Officer
GrantRestricted Share Unit · Derivative 40.4261 $204.93 $8,284.52
Disclosure

SEC source: 0001127602-22-023843 · form4.xml · derivative · entry 1

Bodnar Anne Donovan · CIK 0001629374 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,873.6552

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 40.4261 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for US Employees (the "Plan").

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:00 UTC
Banas Kristy DChief Human Resources Officer
GrantRestricted Share Unit · Derivative 10.7804 $204.93 $2,209.23
Disclosure

SEC source: 0001127602-22-023842 · form4.xml · derivative · entry 3

Banas Kristy D · CIK 0001881896 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 262.6375

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 10.7804 shares

Expires not disclosed

F4 · derivative.exercise_price: Vested shares under the Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F5 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees.

F4 · derivative.exercise_date: Vested shares under the Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F4 · derivative.expiration_date: Vested shares under the Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:00 UTC
Banas Kristy DChief Human Resources Officer
GrantRestricted Share Unit · Derivative 18.8655 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-023842 · form4.xml · derivative · entry 2

Banas Kristy D · CIK 0001881896 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 461.6515

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 18.8655 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan.

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:00 UTC
Banas Kristy DChief Human Resources Officer
GrantRestricted Share Unit · Derivative 32.3408 $204.93 $6,627.60
Disclosure

SEC source: 0001127602-22-023842 · form4.xml · derivative · entry 1

Banas Kristy D · CIK 0001881896 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 442.786

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 32.3408 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan").

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
October 04, 2022 Filed Oct 5, 2022 21:00 UTC
Gebauer Julie JareckeHead of Health, Wealth &Career
SaleOrdinary Shares, nominal value $0.000304635 per share 1,400 $210.00 $294,000.00
Disclosure

SEC source: 0001127602-22-023723 · form4.xml · nonDerivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,755

F1 · shares: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter.

Read SEC document
October 01, 2022 Filed Oct 4, 2022 21:02 UTC GrantOrdinary Shares, nominal value $0.000304635 per share 746 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-023535 · form4.xml · nonDerivative · entry 1

REILLY PAUL C · CIK 0001240439 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 746

F1 · shares: Comprised of 746 restricted share units ("RSUs"), which represent the right to receive ordinary shares, par value $0.000304635 per share, of the Issuer. The RSUs shall vest in full on the earlier of the date of the Issuer's 2023 Annual General Meeting of Shareholders and October 1, 2023.

Read SEC document
September 07, 2022 Filed Sep 9, 2022 20:04 UTC
Krasner Andrew JayChief Financial Officer
OtherDividend Equivalent Rights · Derivative 64 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-022240 · form4.xml · derivative · entry 4

Krasner Andrew Jay · CIK 0001881781 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135.223

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 64 shares

Expires not disclosed

F5 · derivative.exercise_price: The dividend equivalent rights accrued on the reporting person's time-based restricted share unit award and were credited in the form of additional restricted share units that vested and were payable at the same time as the underlying time-based restricted share units. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F5 · derivative.exercise_date: The dividend equivalent rights accrued on the reporting person's time-based restricted share unit award and were credited in the form of additional restricted share units that vested and were payable at the same time as the underlying time-based restricted share units. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F5 · derivative.expiration_date: The dividend equivalent rights accrued on the reporting person's time-based restricted share unit award and were credited in the form of additional restricted share units that vested and were payable at the same time as the underlying time-based restricted share units. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

Read SEC document
September 07, 2022 Filed Sep 9, 2022 20:04 UTC
Krasner Andrew JayChief Financial Officer
SaleOrdinary Shares, nominal value $0.000304635 per share 1,030 $210.26 $216,569.96
Disclosure

SEC source: 0001127602-22-022240 · form4.xml · nonDerivative · entry 3

Krasner Andrew Jay · CIK 0001881781 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Revocable Trust

Disclosed balance after: 2,178

F3 · price: This transaction was executed in multiple trades at prices ranging from $210.21 to $210.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4 · balance_after: Reflects a transfer of 2,709 shares to the reporting person's revocable trust following the vesting and settlement reported above.

Read SEC document
September 07, 2022 Filed Sep 9, 2022 20:04 UTC
Krasner Andrew JayChief Financial Officer
Tax withholdingOrdinary Shares, nominal value $0.000304635 per share 1,758 $204.92 $360,249.36
Disclosure

SEC source: 0001127602-22-022240 · form4.xml · nonDerivative · entry 2

Krasner Andrew Jay · CIK 0001881781 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,200

F1 · shares: Withholding of shares by Issuer incident to the tax payment related to the vesting and settlement of 4,467 restricted share units granted on September 7, 2021.

F2 · balance_after: Does not reflect a transfer of 2,709 shares to the reporting person's revocable trust following the vesting and settlement reported above.

Read SEC document
September 07, 2022 Filed Sep 9, 2022 20:04 UTC
Krasner Andrew JayChief Financial Officer
OtherOrdinary Shares, nominal value $0.000304635 per share 64 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-022240 · form4.xml · nonDerivative · entry 1

Krasner Andrew Jay · CIK 0001881781 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,958

Read SEC document
September 07, 2022 Filed Sep 9, 2022 20:02 UTC
WICKES GENE HHead of Benefits Deliv & Admin
Exercise / conversionStock Option (right to buy) · Derivative 13,925 $0.00 Strike: $110.58 $0.00
Disclosure

SEC source: 0001127602-22-022238 · form4.xml · derivative · entry 8

WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 13,925 shares

Expires 2022-09-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: 100% of the shares underlying the option vested and were exercisable on July 1, 2018.

Read SEC document
September 07, 2022 Filed Sep 9, 2022 20:02 UTC
WICKES GENE HHead of Benefits Deliv & Admin
SaleOrdinary Shares, nominal value $0.000304635 per share 1,975 $209.86 $414,473.50
Disclosure

SEC source: 0001127602-22-022238 · form4.xml · nonDerivative · entry 6

WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,474.836

F5 · price: This transaction was executed in multiple trades at prices ranging from $209.40 to $210.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
September 07, 2022 Filed Sep 9, 2022 20:02 UTC
WICKES GENE HHead of Benefits Deliv & Admin
SaleOrdinary Shares, nominal value $0.000304635 per share 1,712 $208.65 $357,208.80
Disclosure

SEC source: 0001127602-22-022238 · form4.xml · nonDerivative · entry 5

WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,449.836

F4 · price: This transaction was executed in multiple trades at prices ranging from $208.35 to $209.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
September 07, 2022 Filed Sep 9, 2022 20:02 UTC
WICKES GENE HHead of Benefits Deliv & Admin
SaleOrdinary Shares, nominal value $0.000304635 per share 4,132 $207.52 $857,472.64
Disclosure

SEC source: 0001127602-22-022238 · form4.xml · nonDerivative · entry 4

WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,161.836

F3 · price: This transaction was executed in multiple trades at prices ranging from $207.32 to $207.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
September 07, 2022 Filed Sep 9, 2022 20:02 UTC
WICKES GENE HHead of Benefits Deliv & Admin
SaleOrdinary Shares, nominal value $0.000304635 per share 3,477 $206.61 $718,382.97
Disclosure

SEC source: 0001127602-22-022238 · form4.xml · nonDerivative · entry 3

WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,293.836

F2 · price: This transaction was executed in multiple trades at prices ranging from $206.25 to $207.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
September 07, 2022 Filed Sep 9, 2022 20:02 UTC
WICKES GENE HHead of Benefits Deliv & Admin
SaleOrdinary Shares, nominal value $0.000304635 per share 2,629 $205.88 $541,258.52
Disclosure

SEC source: 0001127602-22-022238 · form4.xml · nonDerivative · entry 2

WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,770.836

F1 · price: This transaction was executed in multiple trades at prices ranging from $205.25 to $206.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
September 07, 2022 Filed Sep 9, 2022 20:02 UTC
WICKES GENE HHead of Benefits Deliv & Admin
Exercise / conversionOrdinary Shares, nominal value $0.000304635 per share 13,925 $110.58 $1,539,826.50
Disclosure

SEC source: 0001127602-22-022238 · form4.xml · nonDerivative · entry 1

WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,399.836

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 02, 2022 Filed Sep 6, 2022 20:00 UTC
Gebauer Julie JareckeHead of Health, Wealth &Career
SaleOrdinary Shares, nominal value $0.000304635 per share 1,400 $210.00 $294,002.94
Disclosure

SEC source: 0001127602-22-022093 · form4.xml · nonDerivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,155

F1 · shares: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter.

F2 · price: This transaction was executed in multiple trades at prices ranging from $210.00 to $210.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 26, 2022 Filed Aug 30, 2022 20:00 UTC
WICKES GENE HHead of Benefits Deliv & Admin
Exercise / conversionStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $110.58 $0.00
Disclosure

SEC source: 0001127602-22-021760 · form4.xml · derivative · entry 4

WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,925

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 10,000 shares

Expires 2022-09-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 100% of the shares underlying the option vested and were exercisable on July 1, 2018.

Read SEC document
August 26, 2022 Filed Aug 30, 2022 20:00 UTC
WICKES GENE HHead of Benefits Deliv & Admin
SaleOrdinary Shares, nominal value $0.000304635 per share 10,000 $209.47 $2,094,700.00
Disclosure

SEC source: 0001127602-22-021760 · form4.xml · nonDerivative · entry 2

WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,474.836

Read SEC document
August 26, 2022 Filed Aug 30, 2022 20:00 UTC
WICKES GENE HHead of Benefits Deliv & Admin
Exercise / conversionOrdinary Shares, nominal value $0.000304635 per share 10,000 $110.58 $1,105,800.00
Disclosure

SEC source: 0001127602-22-021760 · form4.xml · nonDerivative · entry 1

WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,474.836

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 18, 2022 Filed Aug 22, 2022 20:00 UTC
WICKES GENE HHead of Benefits Deliv & Admin
Exercise / conversionStock Option (right to buy) · Derivative 22,487 $0.00 Strike: $110.58 $0.00
Disclosure

SEC source: 0001127602-22-021427 · form4.xml · derivative · entry 4

WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,925

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 22,487 shares

Expires 2022-09-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 100% of the shares underlying the option vested and were exercisable on July 1, 2018.

Read SEC document
August 18, 2022 Filed Aug 22, 2022 20:00 UTC
WICKES GENE HHead of Benefits Deliv & Admin
SaleOrdinary Shares, nominal value $0.000304635 per share 22,487 $220.00 $4,947,140.00
Disclosure

SEC source: 0001127602-22-021427 · form4.xml · nonDerivative · entry 2

WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,474.836

Read SEC document
August 18, 2022 Filed Aug 22, 2022 20:00 UTC
WICKES GENE HHead of Benefits Deliv & Admin
Exercise / conversionOrdinary Shares, nominal value $0.000304635 per share 22,487 $110.58 $2,486,612.46
Disclosure

SEC source: 0001127602-22-021427 · form4.xml · nonDerivative · entry 1

WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,961.836

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 17, 2022 Filed Aug 18, 2022 20:00 UTC
WICKES GENE HHead of Benefits Deliv & Admin
Exercise / conversionStock Option (right to buy) · Derivative 398 $0.00 Strike: $110.58 $0.00
Disclosure

SEC source: 0001127602-22-021301 · form4.xml · derivative · entry 7

WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,412

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 398 shares

Expires 2022-09-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 100% of the shares underlying the option vested and were exercisable on July 1, 2018.

Read SEC document
August 17, 2022 Filed Aug 18, 2022 20:00 UTC
WICKES GENE HHead of Benefits Deliv & Admin
SaleOrdinary Shares, nominal value $0.000304635 per share 398 $220.00 $87,560.00
Disclosure

SEC source: 0001127602-22-021301 · form4.xml · nonDerivative · entry 4

WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,474.836

Read SEC document
August 17, 2022 Filed Aug 18, 2022 20:00 UTC
WICKES GENE HHead of Benefits Deliv & Admin
Exercise / conversionOrdinary Shares, nominal value $0.000304635 per share 398 $110.58 $44,010.84
Disclosure

SEC source: 0001127602-22-021301 · form4.xml · nonDerivative · entry 3

WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,872.836

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.